CMA1 and non-small cell lung carcinoma: In contrast, some studies have found that the prognosis in patients with NSCLC is unrelated to the level of MCD [14, 15], but only in stage I patients; those with a high chymase-positive MCD in the peritumoral area have a decreased mortality risk [14].